Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

FDA Approves Expanded Uses for HPV Vaccine to Include Prevention of Certain Vulvar, Vaginal Cancers ROCKVILLE, Md -- September 15, 2008 -- The US Food and Drug Administration (FDA) has approved additional indications for the Human Papillomavirus (HPV) vaccine (Gardasil) to include the prevention of vaginal and vulvar cancer caused by HPV types 16 and 18 in girls and women aged 9 to 26 years. "There is now strong evidence showing that this vaccine can help prevent vulvar and vaginal cancers due to the same viruses for which it also helps protect against cervical cancer," said Jesse L. Goodman, MD, FDA's Center for Biologics Evaluation and Research, Rockville, Maryland. "While vulvar and vaginal cancers are rare, the opportunity to help prevent them is potentially an important additional benefit from immunization against HPV." The new indication approval is based on studies which followed more than 15,000 participants from the original studies for about 2 additional years. Approximately half had received the vaccine as part of the original study, while the other half did not receive the vaccine and served as a control group. Among females who tested negative for HPV types 16 or 18 at the start of the study, the vaccine was highly effective in preventing these types of HPV-related precancerous vulvar and vaginal lesions. In the control group that did not receive the vaccine, 10 individuals developed precancerous vulvar lesions and 9 developed precancerous vaginal lesions, all related to HPV types 16 or 18. No one in the vaccine group developed either kind of precancerous lesion due to HPV types 16 or 18. There was no evidence for benefit among women found to have been previously infected, prior to immunisation, with the HPV types included in the vaccine. The vaccine's label has been revised to note that presently available information is insufficient to support use beyond age 26, the current FDA-approved age. Also, new information has been added showing that the vaccine does not protect against diseases caused by HPV types not contained in the vaccine. The most commonly reported adverse events have included syncope, pain at the injection site, headache, nausea, and fever. SOURCE: US Food and Drug Administration E-mail this page to a friend or colleague! To print, use this version